Mass-spectrometric profiling of cerebrospinal fluid reveals metabolite biomarkers for CNS involvement in varicella zoster virus reactivation

[11] Rieck T(2015)Meningoencephalitis due to varicella zoster virus in aids patients. Report of eleven cases and review of the literature Rev Inst Med Trop Sao Paulo 57 505-1821

[12] Reinhold T(2008)The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features Neurology 70 853-2949

[13] Krause G(2013)Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections J Neurol 260 1813-643

[14] Wichmann O(2016)Cerebrospinal fluid viral load and biomarkers of neuronal and glial cells in Ramsay Hunt syndrome Eur J Neurosci 44 2944-1201

[15] Gilden D(2014)Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls Acta Neuropathol 127 633-1572

[16] Cohrs RJ(2014)Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer’s disease PLoS One 9 e100519-2669

[17] Mahalingam R(2013)Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer’s disease using metabolomics PLoS One 8 e63644-1146

[18] Nagel MA(2015)Sphingomyelin SM(d18:1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-beta42, tau, and phospho-tau-181 levels J Alzheimers Dis 44 1193-490

[19] George BP(2015)An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis Mol BioSyst 11 1563-77

[20] Schneider EB(2008)Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques J Clin Invest 118 2661-837

[11] Rieck T(2015)Meningoencephalitis due to varicella zoster virus in aids patients. Report of eleven cases and review of the literature Rev Inst Med Trop Sao Paulo 57 505-1821

[12] Reinhold T(2008)The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features Neurology 70 853-2949

[13] Krause G(2013)Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections J Neurol 260 1813-643

[14] Wichmann O(2016)Cerebrospinal fluid viral load and biomarkers of neuronal and glial cells in Ramsay Hunt syndrome Eur J Neurosci 44 2944-1201

[15] Gilden D(2014)Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls Acta Neuropathol 127 633-1572

[16] Cohrs RJ(2014)Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer’s disease PLoS One 9 e100519-2669

[17] Mahalingam R(2013)Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer’s disease using metabolomics PLoS One 8 e63644-1146

[18] Nagel MA(2015)Sphingomyelin SM(d18:1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-beta42, tau, and phospho-tau-181 levels J Alzheimers Dis 44 1193-490

[19] George BP(2015)An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis Mol BioSyst 11 1563-77

[20] Schneider EB(2008)Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques J Clin Invest 118 2661-837